• 8891_Labor_Versameb_Forschung_Jun18_foto-eberle
  • 8857_Labor_Versameb_Forschung_Jun18_foto-eberle
  • 8754_Labor_Versameb_Forschung_Jun18_foto-eberle
  • 8720_Labor_Versameb_Forschung_II

Versameb – transforming therapies in regenerative medicine


Versameb is a Swiss based biotechnology platform company focusing on the optimized local delivery of therapeutic proteins.


Versameb has achieved preclinical proof of concept in different injury models by showing a significant acceleration of tissue regeneration after injuries.


Versameb has a novel proprietary technology platform for optimized and tailored, local delivery of therapeutic proteins.


December 2018 | Versameb Ltd raises CHF 5.3 million for the development of mRNA therapies in regenerative medicine